Literature DB >> 25601339

Immunotherapy improves overall survival in pancreatic cancer.

Susan Mayor.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25601339     DOI： 10.1016/S1470-2045(15)70017-3

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  10 in total

1.  The Long Noncoding RNA HOST2 Promotes Gemcitabine Resistance in Human Pancreatic Cancer Cells.

Authors:  Ning An; Donghui Cheng
Journal:  Pathol Oncol Res       Date:  2018-11-07       Impact factor: 3.201

2.  HHLA2 is a novel immune checkpoint protein in pancreatic ductal adenocarcinoma and predicts post-surgical survival.

Authors:  Han Yan; Wanglong Qiu; Anne K Koehne de Gonzalez; Ji-Shu Wei; Min Tu; Chun-Hua Xi; Ye-Ran Yang; Yun-Peng Peng; Wei-Yann Tsai; Helen E Remotti; Yi Miao; Gloria H Su
Journal:  Cancer Lett       Date:  2018-11-14       Impact factor: 8.679

3.  The long non-coding RNA HOTAIR enhances pancreatic cancer resistance to TNF-related apoptosis-inducing ligand.

Authors:  Shan-Zhong Yang; Fei Xu; Tong Zhou; Xinyang Zhao; Jay M McDonald; Yabing Chen
Journal:  J Biol Chem       Date:  2017-05-05       Impact factor: 5.157

4.  Prorenin receptor acts as a potential molecular target for pancreatic ductal adenocarcinoma diagnosis.

Authors:  Arivajiagane Arundhathi; Wen-Han Chuang; Jen-Kun Chen; Shin-E Wang; Yi-Ming Shyr; Jiun-Yu Chen; Wei-Neng Liao; Hsin-Wei Chen; Yi-Min Teng; Chiao-Chih Pai; Chih-Hong Wang
Journal:  Oncotarget       Date:  2016-07-13

5.  Gemcitabine Conjugated Chitosan and Double Antibodies (Abc-GC-Gemcitabine Nanoparticles) Enhanced Cytoplasmic Uptake of Gemcitabine and Inhibit Proliferation and Metastasis In Human SW1990 Pancreatic Cancer Cells.

Authors:  Jun Xiao; Haibo Yu
Journal:  Med Sci Monit       Date:  2017-04-03

Review 6.  Adverse Events of Oncologic Immunotherapy and Their Management.

Authors:  Fedricker Diane Barber
Journal:  Asia Pac J Oncol Nurs       Date:  2019 Jul-Sep

7.  Survival of pancreatic cancer patients is negatively correlated with age at diagnosis: a population-based retrospective study.

Authors:  Hongcheng Wang; Jiazhe Liu; Guanggai Xia; Shizhou Lei; Xiuyan Huang; Xinyu Huang
Journal:  Sci Rep       Date:  2020-04-27       Impact factor: 4.379

8.  Incidence, mortality, and risk factors of immunotherapy-associated hepatotoxicity: A nationwide hospitalization analysis.

Authors:  Simcha Weissman; Saad Saleem; Sachit Sharma; Menashe Krupka; Faisal Inayat; Muhammad Aziz; James H Tabibian
Journal:  Liver Res       Date:  2021-01-23

Review 9.  Current advances of long non-coding RNA highly upregulated in liver cancer in human tumors.

Authors:  Zhonghua Ma; Hesuyuan Huang; Yetao Xu; Xuezhi He; Jirong Wang; Bingqing Hui; Hao Ji; Jing Zhou; Keming Wang
Journal:  Onco Targets Ther       Date:  2017-09-25       Impact factor: 4.147

Review 10.  LncRNAs in pancreatic cancer.

Authors:  Xiaoyi Huang; Xiaosong Zhi; Yisha Gao; Na Ta; Hui Jiang; Jianming Zheng
Journal:  Oncotarget       Date:  2016-08-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.